JD Health International Inc
HKEX:6618

Watchlist Manager
JD Health International Inc Logo
JD Health International Inc
HKEX:6618
Watchlist
Price: 27.3 HKD -4.55% Market Closed
Market Cap: 87.1B HKD
Have any thoughts about
JD Health International Inc?
Write Note

Gross Margin
JD Health International Inc

22.6%
Current
23%
Average
32.8%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
22.6%
=
Gross Profit
12.4B
/
Revenue
54.8B

Gross Margin Across Competitors

Country CN
Market Cap 86.8B HKD
Gross Margin
23%
Country US
Market Cap 2.1T USD
Gross Margin
48%
Country ZA
Market Cap 831B Zac
Gross Margin
38%
Country CN
Market Cap 199.1B USD
Gross Margin
38%
Country CN
Market Cap 139B USD
Gross Margin
62%
Country CN
Market Cap 919.4B HKD
Gross Margin
37%
Country AR
Market Cap 101.2B USD
Gross Margin
46%
Country UY
Market Cap 2.1T MXN
Gross Margin
46%
Country NL
Market Cap 92.8B EUR
Gross Margin
41%
Country US
Market Cap 73.6B USD
Gross Margin
48%
Country CN
Market Cap 398.6B HKD
Gross Margin
16%
No Stocks Found

JD Health International Inc
Glance View

Market Cap
86.8B HKD
Industry
Retail

JD Health International Inc. is not just another player in the rapidly evolving health and wellness landscape; it stands out as a pioneering force driven by technology and innovation. Established in 2015 as a subsidiary of JD.com, one of China's largest e-commerce platforms, JD Health is leveraging its parent company's robust logistics network and cutting-edge technology to reshape healthcare access in China. The company focuses on providing a seamless online healthcare experience, offering a diverse range of services that include online pharmacy sales, health consultations, and prescription management. With growing consumer demand for digital health solutions, JD Health is capitalizing on the shift toward telemedicine and remote healthcare services, positioning itself as a leader in this promising market. For investors, JD Health International Inc. represents a compelling opportunity rooted in strong growth prospects and market leadership. As digital health continues to gain traction, the company has demonstrated impressive revenue growth, propelled by its extensive user base and innovative service offerings. JD Health’s commitment to leveraging advanced technologies like artificial intelligence and big data analytics not only enhances operational efficiency but also improves customer satisfaction and outcomes. Coupled with a solid financial backing from JD.com's established marketplace and logistics capabilities, JD Health is strategically poised to expand its footprint in both urban and rural areas, ultimately aiming to bridge the healthcare accessibility gap in China. As the company navigates the dynamic healthcare environment, its growth trajectory suggests a sustainable business model with substantial long-term value.

Intrinsic Value
34.56 HKD
Undervaluation 21%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
22.6%
=
Gross Profit
12.4B
/
Revenue
54.8B
What is the Gross Margin of JD Health International Inc?

Based on JD Health International Inc's most recent financial statements, the company has Gross Margin of 22.6%.